Galimberti, M <br/><br/>
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.  [electronic resource] 

 -  Bone marrow transplantation  Feb 1994 
 - 197-201 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Bone Marrow Transplantation--adverse effects<br/>Busulfan--therapeutic use<br/>Child<br/>Combined Modality Therapy<br/>Cyclophosphamide--therapeutic use<br/>Cyclosporine--therapeutic use<br/>Dose-Response Relationship, Drug<br/>Female<br/>Graft vs Host Disease--prevention & control<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Prednisolone--therapeutic use<br/>Transplantation, Homologous